Dr. Ali Aldibbiat - Endocrinology Consultant Dr. Ali Aldibbiat - Endocrinology Consultant Book Consultation

Gynecomastia Treatment in Dubai: Male Breast Tissue Care by Dr. Ali Aldibbiat

20+ Years Clinical Experience | FRCP (London) | FRCP (Edinburgh) | PhD Researcher | FACE | Associate Professor | Jumeirah, Dubai

Gynecomastia is a condition many men feel embarrassed to discuss, but it is far more common than most realize. Excess breast tissue in men is not a cosmetic problem waiting for surgery. In the majority of cases it has an identifiable hormonal, medication-related, or physiological cause that can be treated without any procedure at all. Gynecomastia treatment Dubai begins with a thorough hormonal workup to find that cause. Dr. Ali Aldibbiat provides specialist gynecomastia treatment in Dubai at his Jumeirah clinic, establishing whether the breast tissue is true gynecomastia or pseudogynecomastia, identifying the underlying cause, and selecting the most appropriate management.

Understanding the condition

What Is Gynecomastia?

Gynecomastia is the benign proliferation of glandular breast tissue in men, caused by an imbalance between estrogen and androgen activity in breast tissue. It is distinct from pseudogynecomastia, which is fatty tissue deposition in the chest from obesity without true glandular proliferation. True gynecomastia involves palpable, sometimes tender, firm glandular tissue beneath the nipple-areola complex and requires hormonal assessment regardless of severity.

The breast gland in men responds to the same hormonal signals as in women. When the ratio of estrogen to androgen at the breast tissue level rises, whether from excess estrogen production, reduced androgen, or increased androgen-to-estrogen conversion, glandular tissue begins to proliferate. This hormonal imbalance can arise from many causes: puberty, obesity, liver disease, testicular tumors, medications, and hypogonadism among them.

Understanding this distinction matters in clinical practice. A man with pseudogynecomastia from obesity requires weight management, not surgical referral. A man with true gynecomastia from hyperprolactinemia requires cabergoline, not a surgeon. A man with gynecomastia from an anabolic steroid cycle requires careful hormonal recovery management. The approach to gynecomastia treatment in Dubai must be matched to the actual diagnosis.

Discreet medical consultation for gynecomastia assessment in Dubai
Understanding the drivers

What Causes Gynecomastia? The Hormonal and Non-Hormonal Drivers

Identifying the cause is the most important step in gynecomastia treatment Dubai. It determines whether care involves hormonal treatment, medication changes, surgical referral, or reassurance.

Adolescent patient speaking with a healthcare professional during a clinical consultation
Physiological cause

Puberty and Physiological Gynecomastia

Pubertal gynecomastia affects up to 65% of adolescent boys, usually appearing between ages 12 and 15. Most cases resolve within 6 to 24 months, but assessment confirms that no pathological cause is present.

Blood samples prepared for testosterone and hormone testing
Hormonal cause

Hypogonadism and Low Testosterone

Testosterone deficiency shifts breast tissue toward estrogen dominance. Causes can include pituitary disease, hyperprolactinemia, Klinefelter syndrome, orchitis, and age-related hormonal decline.

Clinician measuring a male patient's waist during a metabolic assessment
Metabolic cause

Obesity and Aromatase Excess

Adipose tissue converts testosterone to oestradiol through aromatase. Weight loss can reduce this hormonal drive, although established glandular tissue may not fully regress with weight loss alone.

Prescription tablets in blister packs representing medication-related gynecomastia
Medication-related cause

Medications

Spironolactone, finasteride, anabolic steroids, testosterone therapy, some antipsychotics, antiandrogens, proton pump inhibitors, and antiretrovirals can contribute. A full medication review is essential.

Doctor reviewing MRI imaging during assessment for a pituitary condition
Pituitary cause

Hyperprolactinemia

Elevated prolactin can suppress LH and testosterone, producing secondary hypogonadism. Treating a prolactinoma with cabergoline may restore testosterone and resolve gynecomastia without breast surgery.

Clinician performing an ultrasound assessment in a medical clinic
Other medical causes

Testicular Tumours and Other Causes

Testicular germ-cell tumours can raise beta-hCG and estrogen. Rapid unilateral onset requires examination and ultrasound; liver disease and hyperthyroidism can also disturb the estrogen-androgen balance.

Clinical signs and assessment

Symptoms of Gynecomastia and the Assessment Approach

Gynecomastia may be found during a routine examination or present with noticeable swelling and tenderness. Clinical assessment distinguishes glandular tissue from chest fat and identifies features requiring further investigation.

Breast Swelling and Tenderness

Glandular tissue usually feels firm and rubbery beneath the nipple and may be tender during the early, active phase. Longstanding tissue often becomes less tender as fibrosis develops.

True Gynecomastia vs Pseudogynecomastia

True gynecomastia is a firm, nipple-centred glandular disc. Pseudogynecomastia is softer, diffuse fatty tissue. Examination usually distinguishes them, with ultrasound used when uncertainty remains.

Unilateral vs Bilateral

Bilateral cases are commonly physiological, medication-related, or systemic. Rapid unilateral enlargement, a fixed lump, nipple discharge, or skin changes requires urgent assessment to exclude male breast cancer.

Associated Symptoms to Report

Report rapid progression, testicular changes, reduced libido, fatigue, loss of body hair, headaches, visual changes, new medications, anabolic steroid use, or a family history of breast or testicular cancer.

Knowing when to act

When Should You See a Doctor for Gynecomastia?

Not every case requires urgent investigation. The following changes and associated symptoms warrant specialist gynecomastia treatment Dubai assessment without delay.

Clinical assessment guide Seek specialist review if any of these apply

New Unilateral Changes

A firm, fixed, or rapidly enlarging area, nipple discharge, or skin changes requires urgent assessment to exclude male breast cancer.

New Adult-Onset Gynecomastia

When there is no clear trigger such as puberty, obesity, or medication, hormonal and systemic causes should be investigated.

Signs of Low Testosterone

Reduced libido, worsening fatigue, loss of body hair, or testicular atrophy requires a complete hormonal assessment.

Headaches or Visual Changes

When these symptoms occur alongside gynecomastia, a pituitary cause such as hyperprolactinemia must be considered.

Persistent Pubertal Gynecomastia

Specialist review is appropriate when it persists beyond 24 months or causes significant psychological distress.

Observation may be appropriate

Physiological pubertal gynecomastia without concerning features

An adolescent boy can initially be managed with observation and reassurance because the condition commonly resolves spontaneously. Assessment is still appropriate if symptoms change, the diagnosis is uncertain, it persists beyond two years, or it affects emotional wellbeing.

Book Specialist Assessment
Why timely assessment matters

Complications of Untreated Gynecomastia

The consequences depend on the underlying cause. The main clinical risk is treating the visible breast tissue while the hormonal, medication-related, or medical driver remains unidentified.

Doctor discussing diagnostic findings with a male patient during a medical consultation
Clinical risk

Missed Underlying Diagnosis

Gynecomastia may be the first sign of a testicular tumour, pituitary adenoma, or hypogonadism. Delayed assessment can leave cancer, visual risk, bone loss, muscle decline, or cardiovascular risk unaddressed.

Medical scientist examining tissue samples through a microscope in a laboratory
Treatment window

Fibrosis Can Limit Medical Treatment

Early glandular tissue may respond to treatment. After roughly 12 months it can become progressively fibrotic, making medication less effective and increasing the likelihood that surgery will be needed.

Male patient discussing emotional wellbeing with a healthcare professional
Emotional wellbeing

Psychological Impact

Chest-related embarrassment can reduce confidence and lead to avoidance, anxiety, or depression, particularly during adolescence. These effects are genuine and deserve appropriate clinical support.

Prescription medication capsules representing medication-induced gynecomastia
Preventable progression

Medication-Induced Gynecomastia

If the causative medicine continues unchanged, glandular growth may persist and eventually become fibrotic. Early review can allow a safe alternative before tissue changes become difficult to reverse.

A cause-led diagnostic pathway

How Gynecomastia Is Diagnosed in Dubai

Diagnosis combines clinical examination with targeted hormonal and biochemical testing. Dr. Ali identifies both the type of breast tissue and its underlying cause before any treatment is considered.

Step 01
Doctor conducting a clinical assessment with a male patient Physical examination
Tissue assessment

Clinical Assessment: True vs Pseudo

Palpation distinguishes firm, nipple-centred glandular tissue from soft, diffuse pseudogynecomastia. Unilateral growth, skin changes, or nipple discharge prompts breast imaging to exclude malignancy.

Step 02
Healthcare professional examining a blood sample for hormonal testing Hormonal investigation
Core blood tests

Core Hormonal Panel

Total testosterone and LH assess hypogonadism; estradiol, prolactin, beta-hCG, SHBG, and thyroid testing investigate aromatase excess, pituitary disease, testicular tumours, and reduced free androgen activity.

Step 03
Laboratory technician processing blood samples in a centrifuge Systemic screening
Biochemical assessment

Liver Function and Metabolic Panel

Liver and kidney function, a full blood count, and a complete metabolic panel identify systemic causes that may alter hormone metabolism and require treatment before direct gynecomastia intervention.

Step 04
Doctor and patient reviewing diagnostic medical imaging in a hospital Targeted investigation
Imaging where indicated

Targeted Imaging

Results guide the next test: testicular ultrasound for suspicious hormonal findings, breast ultrasound or mammography for concerning breast changes, and pituitary MRI when prolactin is significantly elevated.

Cause-specific treatment

Gynecomastia Treatment in Dubai: From Medication Review to Surgery

Gynecomastia treatment in Dubai is matched to the underlying cause. Early, active glandular tissue may respond to medical treatment, while established fibrotic gynecomastia usually requires surgical referral.

First-line approach

Treating the Underlying Cause First

Care may involve cabergoline for hyperprolactinemia, hormonal therapy for confirmed hypogonadism, changing a causative medication, or structured weight management for obesity-related cases.

Correct the driver before treating the tissue
Active-phase treatment

Tamoxifen

Tamoxifen blocks estrogen activity at breast tissue receptors and is most effective for recent, tender, non-fibrotic gynecomastia. Response is reviewed during a supervised 3-to-6-month course.

Best considered before fibrosis develops
Alternative medical option

Raloxifene

Raloxifene is another selective estrogen receptor modulator that may benefit active gynecomastia and can be better tolerated by some patients. Suitability is assessed individually by an endocrinologist.

An individualized, off-label option
Established tissue

Surgical Referral for Fibrotic Gynecomastia

Tissue present for 12 to 18 months may no longer respond to medication. Dr. Ali completes the hormonal workup and addresses the cause before referral, helping reduce recurrence after surgery.

Hormonal clearance before surgical care
Cause-led endocrine expertise

Why Choose Dr. Ali Aldibbiat for Gynecomastia Treatment in Dubai?

With 20+ years of specialist experience, dual FRCP fellowships, and a PhD in hormonal and metabolic science, Dr. Ali identifies why gynecomastia developed before recommending medication or surgery.

Dr. Ali Aldibbiat, consultant endocrinologist in Dubai
Fact-checked by Dr. Ali Aldibbiat MD | PhD | FRCP | FACE
MD/PhDEndocrine research
FRCPLondon + Edinburgh
FACEClinical endocrinology
Clinical review

Fact-checked by Dr. Ali Aldibbiat | MD | PhD | FRCP (London) | FRCP (Edinburgh) | FACE | Associate Professor.

Diagnosis before treatment

Cause Identification Before Any Decision

A hormonal panel, medication review, and targeted imaging determine whether care should address prolactin, testosterone, medication exposure, weight, or established breast tissue.

Early medical opportunity

Acting Before Fibrosis

Active gynecomastia may respond to medical treatment during its first 12 months. Early assessment preserves the best chance of improvement without surgery.

Frequently overlooked

Medication-Induced Gynecomastia

Spironolactone, finasteride, anabolic steroids, and some antipsychotics can contribute. Where clinically safe, reviewing the causative medication may prevent progression.

Patient reviews

What Our Patients Say

Genuine Google reviews reflecting Dr. Ali's experience, careful assessment, and patient-centred endocrine care.

“I would like to thank Dr. Ali Aldibbiat. He is an exceptional doctor, highly experienced in his specialty, and fully dedicated to his patients' healing.”

Faten Google Review

“The hospital has very great services and experienced doctors. Thanks to Dr. Ali Aldibbiat, he knew my issues from the first time. Although I have been to many places, no one could find what I was going through.”

Ahmed Alblooshi Dubai · Google Review

“I visit Dr. Ali AlDibbiat, the endocrinologist here, who is excellent and very patient. His treatment has significantly improved my diabetes control.”

Noel Miranda Google Review
Clinic location and access

Gynecomastia Treatment Near Me: Dubai and UAE Service Areas

Dr. Ali Aldibbiat provides specialist, cause-led gynecomastia assessment from his Jumeirah clinic, welcoming patients from across Dubai and the wider UAE.

Serving Dubai and beyond

Specialist hormonal assessment in Jumeirah

The clinic at 109 Century Plaza, Jumeirah Beach Road, serves patients seeking gynecomastia treatment from Jumeirah, Downtown Dubai, DIFC, Dubai Marina, Deira, Bur Dubai, JBR, Al Quoz, and Mirdif. Patients also attend from Abu Dhabi, Sharjah, and across the UAE.

Jumeirah Downtown Dubai DIFC Dubai Marina Deira Bur Dubai JBR Al Quoz Mirdif Abu Dhabi Sharjah

Searching for a gynecomastia treatment, male breast, or endocrinology specialist near you in Dubai? Contact Dr. Ali's clinic to arrange an assessment.

Book an Appointment
Jumeirah 1, Dubai 109 Century Plaza Jumeirah Beach Road
Specialist Dr. Ali Aldibbiat
Clinic 109 Century Plaza, Jumeirah 1
Call +971 58 588 2295 Email a.aldibbiat@draliendo.com

Frequently Asked Questions: Gynecomastia Treatment in Dubai

Gynecomastia is the benign proliferation of glandular breast tissue in men, caused by an imbalance between estrogen and androgen activity in breast tissue. It does not itself require urgent gynecomastia treatment dubai in most cases, but it can be a sign of an underlying hormonal condition such as hypogonadism, hyperprolactinemia, or rarely a testicular tumor that does require treatment. Dr. Ali Aldibbiat provides specialist gynecomastia treatment in Dubai with a complete hormonal assessment to identify the underlying cause.

Gynecomastia is caused by a relative excess of estrogen compared to androgen at the breast tissue level. Common causes include pubertal hormonal changes (most common in adolescents); low testosterone from any cause; obesity and increased aromatase activity; medications (spironolactone, finasteride, anabolic steroids, and certain antipsychotics); hyperprolactinemia from a pituitary adenoma; liver disease; and hyperthyroidism. Identifying the specific cause is the foundation of gynecomastia treatment dubai.

Pubertal gynecomastia resolves spontaneously in most adolescents within 6 to 24 months without treatment. Adult gynecomastia from an identifiable cause (medication, hypogonadism, hyperprolactinemia) usually resolves when the cause is treated, provided the glandular tissue has not yet become fibrotic. Established gynecomastia present for more than 12 to 18 months is unlikely to resolve without gynecomastia treatment dubai: medical or surgical intervention.

Non-surgical gynecomastia treatment in Dubai includes treating the underlying hormonal cause (testosterone replacement for hypogonadism, cabergoline for hyperprolactinemia), stopping or switching a causative medication, medical treatment with tamoxifen or raloxifene to block estrogen action in breast tissue, and weight management where obesity is contributing. Medical gynecomastia treatment dubai is most effective when gynecomastia is active and has been present for less than 12 months.

No. Gynecomastia is a benign, bilateral or unilateral glandular proliferation that is centrally located beneath the nipple. Male breast cancer is typically unilateral, eccentrically placed, firm, fixed, associated with nipple discharge or skin changes, and does not correspond to the pubertal, drug-related, or hormonal pattern of gynecomastia. Any rapidly growing, unilateral, firm, or suspicious breast mass should be assessed urgently. Dr. Ali Aldibbiat always excludes malignancy as part of the initial gynecomastia treatment dubai assessment.

A consultant endocrinologist is the most appropriate specialist for gynecomastia in Dubai, as the condition is fundamentally hormonal and most cases have a treatable endocrine cause. Dr. Ali Aldibbiat provides specialist gynecomastia treatment dubai at 109 Century Plaza, Jumeirah Beach Road, Jumeirah 1. Searching for gynecomastia treatment near me or a gynecomastia treatment Dubai specialist? Book at /contact/book-appointment/ or call +971 58 588 2295.

Vitality Health Calculator Patient Connection Hub